Swedish Orphan Biovitrum

Últimas noticias

Titulares en el idioma original de la fuente.

• 
  Change in number of shares and votes in Sobi (se abre en una pestaña nueva)

  PR Newswire · 30 sept 2026

• 
  Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam (se abre en una pestaña nueva)

  24 sept 2026

• Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates (se abre en una pestaña nueva)

  22 sept 2026

• 
  Sobi and Innate announce partnership is now effective following completion of closing conditions (se abre en una pestaña nueva)

  17 sept 2026

• 
  Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome (se abre en una pestaña nueva)

  GlobeNewswire · 9 sept 2026

• Sobi has completed an issue of class C shares (se abre en una pestaña nueva)

  31 ago 2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative (se abre en una pestaña nueva)

  Simply Wall St. · 15 ago 2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Stock Looks Strong On Returns But Fully Priced On Earnings (se abre en una pestaña nueva)

  Simply Wall St. · 14 ago 2026

• Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III (se abre en una pestaña nueva)

  10 ago 2026

• Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma (se abre en una pestaña nueva)

  10 ago 2026

• German Covid vaccine pioneer BioNTech chooses new chief executive (se abre en una pestaña nueva)

  3 ago 2026

• 
  BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer (se abre en una pestaña nueva)

  GlobeNewswire · 3 ago 2026

• Guido Oelkers to step down as CEO of Sobi in the beginning of 2027 (se abre en una pestaña nueva)

  3 ago 2026

• Swedish Orphan Biovitrum AB (BIOVF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... (se abre en una pestaña nueva)

  GuruFocus.com · 18 jul 2026

• Sobi Q2 2026 report: Significant growth with important pipeline progress (se abre en una pestaña nueva)

  16 jul 2026

• 
  Assessing Swedish Orphan Biovitrum’s Valuation After A Period Of Building Share Price Momentum (se abre en una pestaña nueva)

  Simply Wall St. · 4 may 2026

• 
  Altuviiio (Swedish Orphan Biovitrum) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F (se abre en una pestaña nueva)

  GlobeNewswire · 29 abr 2026

• Swedish Orphan Biovitrum AB (BIOVF) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (se abre en una pestaña nueva)

  GuruFocus.com · 29 abr 2026

• 
  Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) (se abre en una pestaña nueva)

  PR Newswire · 27 mar 2026